SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-15-005320
Filing Date
2015-03-31
Accepted
2015-03-31 19:01:50
Documents
1
Period of Report
2015-03-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 - CANNELL rrd423965.html 4  
1 FORM 4 - CANNELL rrd423965.xml 4 4292
  Complete submission text file 0001181431-15-005320.txt   5689
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3344 N. TORREY PINES COURT SUITE 200 LA JOLLA CA 92037
Business Address
Cannell Thomas R (Reporting) CIK: 0001637822 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 15740928